Clinical Trial Detail

NCT ID NCT02494713
Title Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center, Houston
Indications

prostate adenocarcinoma

Therapies

Degarelix

Estramustine

Docetaxel

Doxorubicin

Ketoconazole

Age Groups: adult

No variant requirements are available.